Exploratory Trial to Estimate Proportion of Patients With Tumor Cell Contaminated Leukapheresis Products With and Without Bortezomib With In-vivo Purging - Multiple Myeloma (MM)
Clinical trial NCT02703779 · COMPLETED
Trial details
- NCT number
- NCT02703779
- Sponsor
- Siddhartha Ganguly
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-10-04
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.